Publisher Correction: A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.
作者:
Yang,Liu [1]
;
Xianwen,Zhang [1]
;
Jianying,Liu [2]
;
Hongjie,Xia [3]
;
Jing,Zou [1]
;
Antonio E,Muruato [1]
;
Sivakumar,Periasamy [2]
;
Chaitanya,Kurhade [3]
;
Jessica A,Plante [4]
;
Nathen E,Bopp [5]
;
Birte,Kalveram [1]
;
Alexander,Bukreyev [2]
;
Ping,Ren [3]
;
Tian,Wang [6]
;
Vineet D,Menachery [4]
;
Kenneth S,Plante [1]
;
Xuping,Xie [2]
;
Scott C,Weaver [2]
;
Pei-Yong,Shi [4]
作者单位:
Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
[1]
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
[2]
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
[3]
Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
[4]
Galveston National Laboratory, Galveston, TX, USA.
[5]
World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA.
[6]
Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA.
[7]
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA. ksplante@utmb.edu.
[8]
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA. ksplante@utmb.edu.
[9]
World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA. ksplante@utmb.edu.
[10]
Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. xuxie@UTMB.edu.
[11]
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA. sweaver@utmb.edu.
[12]
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA. sweaver@utmb.edu.
[13]
World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA. sweaver@utmb.edu.
[14]
Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA. sweaver@utmb.edu.
[15]
Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.
[16]
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.
[17]
Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.
[18]
Sealy Institute for Drug Discovery, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.
[19]
Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.
[20]
DOI
10.1038/s41467-022-33878-6
PMID
36229471
发布时间
2022-10-17
- 浏览0

Nature communications
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文